Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9292585rdf:typepubmed:Citationlld:pubmed
pubmed-article:9292585lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C1414406lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C1817908lld:lifeskim
pubmed-article:9292585lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:9292585pubmed:issue4lld:pubmed
pubmed-article:9292585pubmed:dateCreated1997-9-25lld:pubmed
pubmed-article:9292585pubmed:abstractTextTherapeutic vaccination has been proposed as a strategy to augment immune mechanisms to control viral replication and slow clinical progression of HIV infection to disease. Following recombinant gp160 (r-gp160) immunization in three clinical trials, plasma HIV-1 RNA and cellular proviral DNA were assessed by quantitative polymerase chain reaction (PCR) in 76 HIV-seropositive subjects with CD4+ T cell counts > or = 300/mm3. Immunization increased HIV-specific cellular immune responses (e.g., cytotoxic T lymphocyte [CTL] activities, lymphocyte proliferative responses); however, there were no significant effects of immunization or cellular immune responses on measures of plasma RNA or cellular DNA viral load.lld:pubmed
pubmed-article:9292585pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:languageenglld:pubmed
pubmed-article:9292585pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:citationSubsetIMlld:pubmed
pubmed-article:9292585pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9292585pubmed:statusMEDLINElld:pubmed
pubmed-article:9292585pubmed:monthAuglld:pubmed
pubmed-article:9292585pubmed:issn1077-9450lld:pubmed
pubmed-article:9292585pubmed:authorpubmed-author:MeriganT CTClld:pubmed
pubmed-article:9292585pubmed:authorpubmed-author:ValentineF...lld:pubmed
pubmed-article:9292585pubmed:authorpubmed-author:KunduS KSKlld:pubmed
pubmed-article:9292585pubmed:authorpubmed-author:KatzensteinDDlld:pubmed
pubmed-article:9292585pubmed:authorpubmed-author:EfronBBlld:pubmed
pubmed-article:9292585pubmed:authorpubmed-author:SpinkGGlld:pubmed
pubmed-article:9292585pubmed:issnTypePrintlld:pubmed
pubmed-article:9292585pubmed:day1lld:pubmed
pubmed-article:9292585pubmed:volume15lld:pubmed
pubmed-article:9292585pubmed:ownerNLMlld:pubmed
pubmed-article:9292585pubmed:authorsCompleteYlld:pubmed
pubmed-article:9292585pubmed:pagination269-74lld:pubmed
pubmed-article:9292585pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:meshHeadingpubmed-meshheading:9292585-...lld:pubmed
pubmed-article:9292585pubmed:year1997lld:pubmed
pubmed-article:9292585pubmed:articleTitleEffect of therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA and plasma RNA: relationship to cellular immune responses.lld:pubmed
pubmed-article:9292585pubmed:affiliationCenter for AIDS Research at Stanford, Stanford University Medical Center, California 94305, U.S.A.lld:pubmed
pubmed-article:9292585pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9292585pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9292585pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9292585pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:9292585pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9292585lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9292585lld:pubmed